Standout Papers

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disea... 2018 2026 2020 2023 427
  1. Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) (2018)
    Mohammad Shafi Kuchay, Sonal Krishan et al. Diabetes Care

Immediate Impact

64 standout
Sub-graph 1 of 21

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
1 intermediate paper

Works of Sonal Krishan being referenced

Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
2020
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
2018 Standout

Author Peers

Author Last Decade Papers Cites
Sonal Krishan 477 347 109 457 11 817
Maria‐Benedicte Franzmann 487 343 137 309 13 848
S Sheth 382 201 139 188 8 693
Alexander Hodge 524 208 234 223 23 855
Seishu Tamaki 528 121 234 322 10 826
Riko Tsuji 457 93 236 309 8 728
Daniela Bignamini 536 125 203 295 12 974
Myrto Eliades 345 120 49 216 7 712
Chiu‐Kue Nien 497 366 196 221 12 906
Z.M. Younossi 621 115 285 284 10 712
Adam Lawson 724 230 329 343 15 877

All Works

Loading papers...

Rankless by CCL
2026